BioSpace News Archive

Business

Alexion Reports Fourth Quarter and Full Year 2018 Results

4Q18 total revenues of $1,128.8 million, a 24 percent increase over 4Q17 and a 30 percent volume increase

February 4, 2019

·

27 min read

Policy

Aurora Cannabis Partner Radient Technologies Receives Standard Processing License

Disruptive Technology an Important Component of Aurora’s Derivative Products Strategy

February 4, 2019

·

7 min read

BioMidwest

Trust is High Priority for Massage Consumers, Prefer AMTA Members

the American Massage Therapy Association continues to be the #1 choice for adults, those who have had a massage in the past year, as well as massage professionals in terms of awareness, overall impression, credibility, respect and having the best trained and educated therapists.

February 4, 2019

·

3 min read

Business

Evogene Appoints Dr. Adrian Percy to Its Board of Directors

Dr. Percy most recently served as Head of Research & Development for the Crop Science division of Bayer and has broad senior management experience in the agricultural industry

February 4, 2019

·

3 min read

Crescita Therapeutics Inc.™ and Tetra Natural Health Collaborate to Enhance Transdermal Delivery of Beta-Caryophyllene in Tetra’s Dermatology Product Portfolio

Crescita Therapeutics Inc. today announced an agreement to develop an enhanced version of Tetra’s dermatology portfolio using Crescita’s patented transdermal delivery technologies: Multiplexed Molecular Penetration Enhancer (“MMPE™") and DuraPeel™.

February 4, 2019

·

7 min read

Takeda to Highlight Advancements in Rare Lysosomal Storage Disorders at Global Scientific Meeting

12 presentations will be presented across 3 lysosomal storage disorders, underscoring Takeda’s commitment to patients with rare diseases

February 4, 2019

·

10 min read

Pharm Country

Dr. Reddy’s Laboratories Continues its Voluntary Nationwide Recall of Levetiracetam in 0.54% Sodium Chloride Injection 1500mg/100mL Due to Mislabeling

Dr. Reddy’s Laboratories Ltd. announced that its wholly owned subsidiary, Dr Reddy’s Laboratories, Inc, is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetam in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL single-dose infusion bags to the hospital level in U.S.A.

February 4, 2019

·

7 min read

Business

QIAGEN Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project

QCI is a powerful, high quality decision support solution for rapid interpretation of hereditary diseases

February 4, 2019

·

1 min read

Drug Development

BioArctic Announces That Eisai Will Initiate Phase 3 Confirmatory Study With BAN2401 in Early Alzheimer’s Disease

BioArctic AB announced that Eisai stated at their Q3 FY2018 Financial Results Meeting on February 4, 2019 that a single Phase 3 confirmatory study of BAN2401 in early Alzheimer´s disease patients is under preparation and planned to be initiated within Eisai’s FY2018 i.e. the first quarter 2019.

February 4, 2019

·

6 min read

Business

Statement - Let’s recognize and support the contributions of Canada’s medical residents

National Resident Awareness Week is an opportunity to recognize the contribution of over 12,000 medical residents who deliver care to Canadians across the country.

February 4, 2019

·

1 min read